IndiaTickerLatest filing: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec Limited
ObservedCompany dossier
Panacea Biotec
NSE:PANACEABIO · ISIN INE922B01023
- Close
- ₹423.85 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Panacea Biotec
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹163.5 Cr · PAT ₹4.4 Cr.
Exchange XBRLLatest ownership: promoter group 72.48% and public 27.52% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec Limited
NSE · exchange filing
Observed
Source filing Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
BSE · exchange filing
Observed
Archived filing Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec Limited
NSE · exchange filing
Observed
Source filing Panacea Biotec Ltd - 531349 - Updates In Relation To Receipt Of Four Awards Dated March 19, 2026 From The Presiding Officer (In The Rank Of Additional District Judge) Of Industrial Tribunal, S.A.S. Nagar, Mohali
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹163.5 Cr
- Profit after tax
- ₹4.4 Cr
- EPS
- ₹0.74
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 72.48%
- Public
- 27.52%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL